Decheng Capital »

Longboard Pharmaceuticals In shares owned by Decheng Capital

Quarter-by-quarter ownership of Longboard Pharmaceuticals In (LBPH) shares owned by Decheng Capital from 13F filings

Historical chart of Decheng Capital investment in Longboard Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Longboard Pharmaceuticals In held by Decheng Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Longboard Pharmaceuticals In by Decheng Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.9M 56k 33.33

More positions owned by Decheng Capital

Cg Oncology (CGON)
Nuvation Bio (NUVB)
Phathom Pharmaceuticals (PHAT)
Arcus Biosciences Incorporated (RCUS)
Krystal Biotech (KRYS)
Illumina (ILMN)
Zentalis Pharmaceuticals (ZNTL)
BeyondSpring SHS (BYSI)
Newamsterdam Pharma Co Nv (NAMS)
Merus N V (MRUS)
Helix Acquisition Corp
Crinetics Pharmaceuticals In (CRNX)
Legend Biotech Corp- Adr (LEGN)
Cytokinetics (CYTK)
Aura Biosciences (AURA)

View all positions for Decheng Capital

Top funds holding Longboard Pharmaceuticals In

Farallon Capital Management
T. Rowe Price Associates
BlackRock
Cormorant Asset Management
BlackRock
Viking Global Investors
Vanguard Group
Woodline Partners
Pictet Asset Management Holding SA
Jennison Associates
Siren
State Street Corporation
Geode Capital Management
Driehaus Capital Management
Parkman Healthcare Partners

View all funds holding Longboard Pharmaceuticals In